Related Experiment Video

Updated: Jun 20, 2026

Multi-Gene Single Nucleotide Polymorphism Detection in Gastric Cancer Based on Ion Semiconductor Sequencing Platform
06:21

Multi-Gene Single Nucleotide Polymorphism Detection in Gastric Cancer Based on Ion Semiconductor Sequencing Platform

Published on: May 10, 2024

IFNGR1 polymorphisms in Thai malaria patients

Izumi Naka1, Jintana Patarapotikul, Hathairad Hananantachai

  • 1Doctoral Program in Life System Medical Sciences, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Ibaraki 305-8575, Japan.

Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases
|August 29, 2009
PubMed

Insights

Interferon-gamma receptor 1 (IFNGR1) gene variations were not significantly associated with cerebral malaria in Thai adults. This suggests IFNGR1 polymorphisms are unlikely to be a major genetic factor for severe malaria in this population.

Area of Science:

  • Immunogenetics
  • Infectious Diseases
  • Human Genetics

Background:

  • Interferon-gamma (IFN-gamma) is implicated in malaria pathogenesis.
  • Genetic factors influencing severe malaria, like cerebral malaria, are crucial to identify.

Purpose of the Study:

  • To investigate the association between Interferon-gamma receptor 1 (IFNGR1) gene polymorphisms and cerebral malaria in a Thai population.
  • To determine if specific IFNGR1 genetic variations contribute to the development of severe Plasmodium falciparum malaria.

Main Methods:

  • Genotyping of 312 adult malaria patients (203 mild, 109 cerebral malaria) from northwest Thailand.
  • Analysis of six single nucleotide polymorphisms (SNPs) and one microsatellite marker within the IFNGR1 gene.
  • Case-control association study to compare allele and genotype frequencies between mild and cerebral malaria groups.

Main Results:

  • No significant association was found between the studied IFNGR1 polymorphisms and cerebral malaria.
  • The genetic variations in IFNGR1 did not appear to be a major determinant for developing cerebral malaria in this cohort.

Conclusions:

  • IFNGR1 polymorphisms are unlikely to be a significant genetic risk factor for cerebral malaria in the Thai population.
  • These findings contribute to understanding the genetic basis of malaria severity and inform future research on IFNG gene polymorphisms in Thai patients.

More Related Videos

A Multi-detection Assay for Malaria Transmitting Mosquitoes09:00

A Multi-detection Assay for Malaria Transmitting Mosquitoes

Published on: February 28, 2015

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment07:26

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment

Published on: July 18, 2017

Related Concept Videos

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Malaria01:29

Malaria

Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase01:27

Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase

Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...